Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 24;8(4):e61356.
doi: 10.1371/journal.pone.0061356. Print 2013.

Salivary biomarkers for detection of systemic diseases

Affiliations

Salivary biomarkers for detection of systemic diseases

Nilminie Rathnayake et al. PLoS One. .

Abstract

Background and objective: Analysis of inflammatory biomarkers in saliva could offer an attractive opportunity for the diagnosis of different systemic conditions specifically in epidemiological surveys. The aim of this study was to investigate if certain salivary biomarkers could be used for detection of common systemic diseases.

Materials and methods: A randomly selected sample of 1000 adults living in Skåne, a county in the southern part of Sweden, was invited to participate in a clinical study of oral health. 451 individuals were enrolled in this investigation, 51% women. All participants were asked to fill out a questionnaire, history was taken, a clinical examination was made and stimulated saliva samples were collected. Salivary concentrations of IL-1β, -6, -8, TNF-α, lysozyme, MMP-8 and TIMP-1 were determined using ELISA, IFMA or Luminex assays.

Results: Salivary IL-8 concentration was found to be twice as high in subjects who had experience of tumour diseases. In addition, IL-8 levels were also elevated in patients with bowel disease. MMP-8 levels were elevated in saliva from patients after cardiac surgery or suffering from diabetes, and muscle and joint diseases. The levels of IL-1β, IL-8 and MMP-8, as well as the MMP-8/TIMP-1 ratio were higher in subjects with muscle and joint diseases.

Conclusion: Biomarkers in saliva have the potential to be used for screening purposes in epidemiological studies. The relatively unspecific inflammatory markers used in this study can not be used for diagnosis of specific diseases but can be seen as markers for increased systemic inflammation.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist. Prof. Timo Sorsa, University of Helsinki, Finland, is an inventor of US-Patent #5736341 on/describing/addressing technology on oral fluid diagnostic MMP-8 immunoassay, and this technology has been utilized in their paper. The patent is owned by Oy Medixbiochemica Ab/Ltd, Kauniainen, Finland, and according to the contract between Prof. Timo Sorsa and Medix Biochemica Oy/Ab/Ltd Prof. Timo Sorsa has received royalties from the Medix-company. Prof. Timo Sorsa confirms that this does not alter their adherence to all PLOS ONE polices on sharing data and materials.

References

    1. Lee YH, Wong DT (2009) Saliva: an emerging biofluid for early detection of diseases. Am J Dent 22: 241–248. - PMC - PubMed
    1. Fox PC (1993) Salivary monitoring in oral diseases. Ann N Y Acad Sci 694: 234–237. - PubMed
    1. Kaufman E, Lamster IB (2000) Analysis of saliva for periodontal diagnosis–a review. J Clin Periodontol 27: 453–465. - PubMed
    1. Seymour GJ, Gemmell E (2001) Cytokines in periodontal disease: where to from here? Acta Odontol Scand 59: 167–173. - PubMed
    1. Kaufman E, Lamster IB (2002) The diagnostic applications of saliva-a review. Crit Rev Oral Biol Med 13: 197–212. - PubMed

Publication types